Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia

Supportive Care in Cancer

Volumn 19, Issue 8, 2011, Pages 1151-1158

  Ahn, Shin ^a   Lee, Yoon Seon ^a   Chun, Yun Hee ^a   Kwon, In Ho ^a   Kim, Won ^a   Lim, Kyung Soo ^a   Kim, Tae Won ^a   Lee, Kyoo Hyung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cancer; Chemotherapy; Febrile neutropenia; Prognosis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; C REACTIVE PROTEIN; CEPHALOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE DURATION; FEBRILE NEUTROPENIA; FEMALE; GENDER; HUMAN; HYPOTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; TACHYPNEA; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; C-REACTIVE PROTEIN; CONFIDENCE INTERVALS; FEMALE; FEVER; HUMANS; INTERNATIONALITY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; NEUTROPENIA; ODDS RATIO; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 80051596038     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-010-0928-4     Document Type: Article

References (32)

1. C Viscoli E Castagnola 2002 Treatment of febrile neutropenia: what is new? Curr Opin Infect Dis 15 377 382 12130933 10.1097/00001432-200208000-00004 (Pubitemid 34816425)
2. GP Bodey M Buckley YS Sathe EJ Freireich 1966 Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia Ann Intern Med 64 328 340 5216294 1:STN:280:DyaF28%2Fnt1OmtQ%3D%3D
3. O Neth I Hann MW Turner NJ Klein 2001 Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study Lancet 358 614 618 11530147 10.1016/S0140-6736(01)05776-2 1:CAS:528: DC%2BD3MXmt1yisr4%3D (Pubitemid 32786825)
4. RJ Klaassen TR Goodman B Pham JJ Doyle 2000 "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia J Clin Oncol 18 1012 1019 10694551 1:STN:280:DC%2BD3c7mtVOntw%3D%3D (Pubitemid 30123777)
5. K Ohyashiki 2004 Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients Clin Infect Dis 39 Suppl 1 S56 S58 15250023 10.1086/383056 (Pubitemid 38971478)
6. JA Talcott R Finberg RJ Mayer L Goldman 1988 The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation Arch Intern Med 148 2561 2568 3196123 10.1001/archinte.148.12.2561 1:STN:280:DyaL1M%2FmtFamuw%3D%3D (Pubitemid 19048173)
7. JA Talcott A Whalen J Clark PP Rieker R Finberg 1994 Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule J Clin Oncol 12 107 114 8270967 1:STN:280:DyaK2c%2Fps1Sntg%3D%3D (Pubitemid 24020628)
8. J Klastersky M Paesmans EB Rubenstein M Boyer L Elting R Feld J Gallagher J Herrstedt B Rapoport K Rolston J Talcott 2000 The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients J Clin Oncol 18 3038 3051 10944139 1:STN:280:DC%2BD3cvivFCrsg%3D%3D (Pubitemid 30644129)
9. WT Hughes D Armstrong GP Bodey EJ Bow AE Brown T Calandra R Feld PA Pizzo KV Rolston JL Shenep LS Young 2002 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 730 751 11850858 10.1086/339215 (Pubitemid 34194843)
10. A Glasmacher M von Lilienfeld-Toal S Schulte C Hahn IG Schmidt-Wolf A Prentice 2005 An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients Clin Microbiol Infect 11 Suppl 5 17 23 16138815 10.1111/j.1469-0691.2005.01239.x 1:CAS:528: DC%2BD2MXhtFegtbbJ (Pubitemid 41348481)
11. ND Baskaran GG Gan K Adeeba IC Sam 2007 Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia Int J Infect Dis 11 513 517 17459753 10.1016/j.ijid.2007.02.002 (Pubitemid 47626044)
12. H Innes SL Lim A Hall SY Chan N Bhalla E Marshall 2008 Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice Support Care Cancer 16 485 491 17899215 10.1007/s00520-007-0334-8 (Pubitemid 351502757)
13. J Klastersky L Ameye J Maertens A Georgala F Muanza M Aoun A Ferrant B Rapoport K Rolston M Paesmans 2007 Bacteraemia in febrile neutropenic cancer patients Int J Antimicrob Agents 30 Suppl 1 S51 S59 17689933 10.1016/j.ijantimicag.2007.06.012 1:CAS:528:DC%2BD2sXhtFeitLvP (Pubitemid 47505301)
14. A Uys BL Rapoport R Anderson 2004 Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score Support Care Cancer 12 555 560 15197637 10.1007/s00520-004-0614-5 (Pubitemid 39062546)
15. A Uys BL Rapoport H Fickl PW Meyer R Anderson 2007 Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10 Eur J Cancer Care (Engl) 16 475 483 10.1111/j.1365-2354.2007.00780.x 1:STN:280:DC%2BD2snitVKmtg%3D%3D
16. ND Baskaran GG Gan K Adeeba 2008 Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients Ann Hematol 87 563 569 18437382 10.1007/s00277-008-0487-7
17. ME Santolaya AM Alvarez A Becker J Cofre N Enriquez M O'Ryan E Paya J Pilorget C Salgado J Tordecilla M Varas M Villarroel T Viviani M Zubieta 2001 Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever J Clin Oncol 19 3415 3421 11454890 1:STN:280:DC%2BD3MvgtlKmsg%3D%3D (Pubitemid 32642195)
18. ME Santolaya AM Alvarez CL Aviles A Becker A King C Mosso M O'Ryan E Paya C Salgado P Silva S Topelberg J Tordecilla M Varas M Villarroel T Viviani M Zubieta 2008 Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial Pediatr Infect Dis J 27 538 543 18458649 10.1097/INF.0b013e3181673c3c
19. C Arber JR Passweg U Fluckiger M Pless M Gregor A Tichelli JA Schifferli A Gratwohl 2000 C-reactive protein and fever in neutropenic patients Scand J Infect Dis 32 515 520 11055657 10.1080/003655400458802 1:CAS:528: DC%2BD3cXnvVers7o%3D
20. S Hamalainen T Kuittinen I Matinlauri T Nousiainen I Koivula E Jantunen 2008 Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome Scand J Infect Dis 41 14 20 10.1080/00365540802454706
21. A Engel E Mack P Kern WV Kern 1998 An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients Infection 26 213 221 9717678 10.1007/BF02962366 1:CAS:528: DyaK1cXotV2ktbo%3D (Pubitemid 28388878)
22. T Lehrnbecher D Venzon M de Haas SJ Chanock J Kuhl 1999 Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia Clin Infect Dis 29 414 419 10476751 10.1086/520224 1:STN:280:DyaK1MvgsVCjsw%3D%3D (Pubitemid 29380209)
23. M Diepold P Noellke U Duffner U Kontny R Berner 2008 Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk BMC Infect Dis 8 28
24. M von Lilienfeld-Toal A Schneider K Orlopp C Hahn-Ast A Glasmacher F Stuber 2006 Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies Support Care Cancer 14 1241 1245 10.1007/s00520-006-0081-2 (Pubitemid 44810851)
25. S Reuter WV Kern A Sigge H Dohner R Marre P Kern H von Baum 2005 Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies Clin Infect Dis 40 1087 1093 15791505 10.1086/428732 1:CAS:528:DC%2BD2MXjvVynsLc%3D (Pubitemid 40490230)
26. WV Kern K Klose AS Jellen-Ritter M Oethinger J Bohnert P Kern S Reuter H von Baum R Marre 2005 Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia Eur J Clin Microbiol Infect Dis 24 111 118 15714332 10.1007/s10096-005-1278-x 1:STN:280: DC%2BD2M7kt12huw%3D%3D (Pubitemid 40487379)
27. A Gafter-Gvili A Fraser M Paul L Leibovici 2005 Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients Ann Intern Med 142 979 995 15968013 (Pubitemid 40840313)
28. BH Segal AG Freifeld LR Baden AE Brown C Casper E Dubberke M Gelfand JN Greene MG Ison JI Ito JE Karp DR Kaul E King E Mackler G Marcucci JG Montoya AM Engemann K Rolston AS The 2008 Prevention and treatment of cancer-related infections J Natl Compr Canc Netw 6 122 174 18319048 (Pubitemid 351340523)
29. PA Pizzo 1993 Management of fever in patients with cancer and treatment-induced neutropenia N Engl J Med 328 1323 1332 8469254 10.1056/NEJM199305063281808 1:STN:280:DyaK3s3is1SjtA%3D%3D (Pubitemid 23131375)
30. LC Hartmann LK Tschetter TM Habermann LP Ebbert PS Johnson JA Mailliard R Levitt VJ Suman TE Witzig HS Wieand LL Miller CG Moertel 1997 Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia N Engl J Med 336 1776 1780 9187067 10.1056/NEJM199706193362502 1:CAS:528:DyaK2sXlt12itLo%3D (Pubitemid 27262173)
31. A Ravaud C Chevreau L Cany P Houyau N Dohollou H Roche P Soubeyran F Bonichon J Mihura H Eghbali I Tabah BN Bui 1998 Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial J Clin Oncol 16 2930 2936 9738560 1:CAS:528:DyaK1cXmtFSls78%3D (Pubitemid 28417411)
32. E Vellenga CA Uyl-de Groot R de Wit HJ Keizer B Lowenberg MA ten Haaft TJ de Witte CA Verhagen GJ Stoter FF Rutten NH Mulder WM Smid EG de Vries 1996 Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia J Clin Oncol 14 619 627 8636779 1:CAS:528:DyaK28XhsV2ltrc%3D